Tscan Therapeutics shares owned by Troluce Capital Advisors
Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Troluce Capital Advisors
from 13F filings
Historical chart of Troluce Capital Advisors investment in Tscan Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tscan Therapeutics held by Troluce Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Tscan Therapeutics by Troluce Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $218k | 150k | 1.45 |
| 2025-03-31 | $116k | 84k | 1.38 |
| 2024-12-31 | $161k | 53k | 3.04 |
| 2024-09-30 | $264k | 53k | 4.98 |
| 2024-06-30 | $543k | 93k | 5.85 |